TABLE 2.
Clinical outcomes of patients with K. pneumoniae bacteremiaa
| Variable | Tigecycline nonsusceptible (n = 43) | Tigecycline susceptible (n = 43) | P |
|---|---|---|---|
| Appropriate empirical antimicrobial therapy | 20 (46.5) | 39 (90.7) | <0.001 |
| Appropriate definite antimicrobial therapy | 35 (81.4) | 39 (90.7) | 0.351 |
| Median length of stay in days after bacteremia (IQR) | 13.0 (8.0–25.0) | 14.0 (6.0–23.0) | 0.983 |
| Septic shock when bacteremia | 23 (53.5) | 31 (72.1) | 0.074 |
| Mortality | |||
| In-hospital mortality | 18 (41.9) | 12 (27.9) | 0.175 |
| 14-day mortality | 13 (30.2) | 9 (20.9) | 0.323 |
| 28-day mortality | 18 (41.9) | 10 (23.3) | 0.066 |
a
Data are presented as the number (%) of patients, unless stated otherwise in column 1. IQR, interquartile range.